Heron Therapeutics
HRTX
#10276
Rank
NZ$87.82 M
Marketcap
NZ$0.46
Share price
-4.39%
Change (1 day)
-76.32%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2026 (TTM): NZ-$0.33

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$0.35. In 2025 the company made an earnings per share (EPS) of NZ-$0.22 a decrease over its 2024 EPS that were of NZ-$0.16.

EPS history for Heron Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$0.3350.17%
2025NZ-$0.2233.33%
2024NZ-$0.16
2022NZ-$3.16-23.11%
2021NZ-$4.11-10%
2020NZ-$4.57-0%
2019NZ-$4.571.21%
2018NZ-$4.52
2016NZ-$8.3254.76%
2015NZ-$5.371.73%
2014NZ-$5.28-16.23%
2013NZ-$6.3191.67%
2012NZ-$3.29

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
SurModics
SRDX
NZ-$2.25 547.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Pacira Biosciences
PCRX
NZ$0.64-284.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$4.73-1,463.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
NZ-$0.0000000000-100.00%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Nektar Therapeutics
NKTR
NZ-$12.25 3,426.32%๐Ÿ‡บ๐Ÿ‡ธ USA